Metagenomi, Inc. Common Stock
Metagenomi, Inc. Common Stock (MGX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MGX · as of Jun 9, 2026
Key Statistics
Explore Metagenomi, Inc. Common Stock Data
mgx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 80.0%
The MGX analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $14.50, representing +1024.03% upside from the current price of $1.29.
Competitors & Peers
mgx competitorsMGX
ADVM
ALXO
ARTV
ATYR
CNTBStock Performance
Full HistoryAbout Metagenomi, Inc. Common Stock
Metagenomi, Inc. Common Stock Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developing therapeutic solutions for patients. The company utilizes a distinctive genome editing toolkit, sou…
what is metagenomi, inc. common stock · mgx stock overview · metagenomi, inc. common stock company profile · who is metagenomi, inc. common stock ceo · mgx NASDAQ · metagenomi, inc. common stock headquarters · metagenomi, inc. common stock business segments
About Stock Overview & Key Data
Metagenomi, Inc. Common Stock (MGX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 6, 2006. As of the latest trading session, MGX stock price is $1.29, with a market capitalization of $48.6M. The stock has returned -22.75% over the past 12 months and -20.37% year-to-date.
According to 5 Wall Street analysts, the consensus rating for Metagenomi, Inc. Common Stock stock is Buy, with an average 12-month price target of $14.50. In fiscal year 2025, Metagenomi, Inc. Common Stock reported revenue of $25.2M and net income of -$87.9M. For detailed data — including Metagenomi, Inc. Common Stock revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Metagenomi, Inc. Common Stock (MGX) stock price is $1.29. The stock is traded on NASDAQ under the ticker symbol MGX. The 52-week range is $1.24 – $3.95.